SORANA POP: Open Payments
NPI 1164802690 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 95 payments from 25 companies in 2025. Trend: 2023 $1,351 · 2024 $2,011 · 2025 $1,902
Food & beverage: $1,902
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $317 |
| ABBVIE INC. | 16 | $274 |
| Novo Nordisk Inc | 11 | $161 |
| Amgen Inc. | 9 | $142 |
| GlaxoSmithKline, LLC. | 7 | $140 |
| Sumitomo Pharma America, Inc. | 5 | $124 |
| PFIZER INC. | 4 | $72 |
| Eisai Inc. | 3 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, GEMTESA, CREON, OTEZLA, LINZESS, VRAYLAR, Ozempic.
Industry payments across AZ — which companies pay providers there.
